MedTrace Logo

Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?

NCT06025331 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2023-11-07

No results posted yet for this study

Summary

The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.

Conditions

  • Arthroplasty, Replacement, Shoulder
  • Shoulder Osteoarthritis

Interventions

PROCEDURE

BIO-RSA

Bony increased offset-reversed shoulder arthroplasty(BIO-RSA) will be performed.

PROCEDURE

RSA

Conventional reversed shoulder arthroplasty(RSA) will be performed.

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • Sykehuset Telemark

    collaborator OTHER_GOV

  • University Hospital, Akershus

    collaborator OTHER

  • Lovisenberg Diakonale Hospital

    lead OTHER

Principal Investigators

  • Sigbjørn Dimmen, PhD · University of Oslo

  • Kjersti Kaul Jenssen, PhD · Lovisenberg Diaconal Hospital

  • Christian Owesen, PhD · Lovisenberg Diaconal Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2033-08-01
Completion
2033-08-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06025331 on ClinicalTrials.gov